Carlsbad, 92008, CA,
United States
Tyra Biosciences, Inc. Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Tyra Biosciences, Inc. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 25 Tyra Biosciences, Inc. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Tyra Biosciences, Inc. has purchased the following applications: Microsoft 365 for Collaboration in 2018, docs24 Platform for Document Management in 2023, GoDaddy for Application Hosting and Computing Services in 2018 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Tyra Biosciences, Inc. is running and its propensity to invest more and deepen its relationship with Microsoft , docs24 , GoDaddy or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Tyra Biosciences, Inc. revenues, which have grown to $3.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Tyra Biosciences, Inc. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2018 | 2018 |
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| docs24 | Legacy | docs24 Platform | Document Management | Content Management | n/a | 2023 | 2023 |
In 2023, Tyra Biosciences, Inc. engaged the docs24 Platform to manage trial-related documentation for its TYR300 clinical trial, SURF-301, with operational coverage noted in Europe. The docs24 Platform appears as a third-party provider on the CTIS trial record, indicating assignment of document handling and support activities to clinical operations for that program.
Implementation scope centered on Document Management capabilities, inferred from the CTIS third-party listing to include clinical document management and print and fulfilment for trial materials. The deployment followed a third-party provider model, delivering controlled document lifecycle workflows, version control, role-based access and audit trail functionality, together with distribution orchestration for site-facing materials. Operational coverage focused on clinical operations and regulatory documentation flows for the TYR300 program across European sites, and governance adjustments likely included formalized document release workflows and fulfilment approval steps to align documentation processes with trial quality and regulatory requirements.
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| GoDaddy | Legacy | GoDaddy | Application Hosting and Computing Services | IaaS | n/a | 2018 | 2018 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||